OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 126
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
Potential Influence of Antifungal-drug Resistant Pathogens in Patients with Cholangiocarcinoma and the Application of Nanoparticle Mechanisms as Novel Antifungal and Anticancer Agents
Conrad Chibunna Achilonu, Tsepo Ramatla, Maleke Maleke, et al.
Current Clinical Microbiology Reports (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Conrad Chibunna Achilonu, Tsepo Ramatla, Maleke Maleke, et al.
Current Clinical Microbiology Reports (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Epidemiology of cholangiocarcinoma
Maria Qurashi, Mathew Vithayathil, Shahid A. Khan
European Journal of Surgical Oncology (2023), pp. 107064-107064
Open Access | Times Cited: 38
Maria Qurashi, Mathew Vithayathil, Shahid A. Khan
European Journal of Surgical Oncology (2023), pp. 107064-107064
Open Access | Times Cited: 38
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial
Arndt Vogel, Anna Saborowski, Patrick Wenzel, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 8, pp. 734-744
Open Access | Times Cited: 14
Arndt Vogel, Anna Saborowski, Patrick Wenzel, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 8, pp. 734-744
Open Access | Times Cited: 14
Artificial intelligence in liver cancer — new tools for research and patient management
Julien Caldéraro, Laura Žigutytė, Daniel Truhn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 585-599
Closed Access | Times Cited: 11
Julien Caldéraro, Laura Žigutytė, Daniel Truhn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 585-599
Closed Access | Times Cited: 11
Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies
Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9
Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9
The causal relationship between gut microbiota and biliary tract cancer: comprehensive bidirectional Mendelian randomization analysis
Kui Wang, Suijian Wang, Xianzheng Qin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Kui Wang, Suijian Wang, Xianzheng Qin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring
Ningyuan Wen, Dingzhong Peng, Xianze Xiong, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Ningyuan Wen, Dingzhong Peng, Xianze Xiong, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications
Andrei Jipa, Mina S. Makary
Cancers (2024) Vol. 16, Iss. 7, pp. 1271-1271
Open Access | Times Cited: 8
Andrei Jipa, Mina S. Makary
Cancers (2024) Vol. 16, Iss. 7, pp. 1271-1271
Open Access | Times Cited: 8
Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
Ziting Peng, Jianhui Dong, Shuyao Tang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Ziting Peng, Jianhui Dong, Shuyao Tang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Effectiveness and safety of transarterial chemoembolization combined with PD-1 inhibitors and lenvatinib for unresectable intrahepatic cholangiocarcinoma
Jintao Huang, Di Hu, Xin Hong, et al.
European Radiology Experimental (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Jintao Huang, Di Hu, Xin Hong, et al.
European Radiology Experimental (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies
Lorenza Rimassa, Shahid A. Khan, Bas Groot Koerkamp, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101171-101171
Open Access | Times Cited: 1
Lorenza Rimassa, Shahid A. Khan, Bas Groot Koerkamp, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101171-101171
Open Access | Times Cited: 1
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials
Julien Edeline, John Bridgewater, Boris Campillo‐Gimenez, et al.
Hepatology (2023) Vol. 79, Iss. 1, pp. 96-106
Closed Access | Times Cited: 17
Julien Edeline, John Bridgewater, Boris Campillo‐Gimenez, et al.
Hepatology (2023) Vol. 79, Iss. 1, pp. 96-106
Closed Access | Times Cited: 17
Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence
Diamantis I. Tsilimigras, Yutaka Endo, Alfredo Guglielmi, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 7, pp. 4427-4435
Closed Access | Times Cited: 6
Diamantis I. Tsilimigras, Yutaka Endo, Alfredo Guglielmi, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 7, pp. 4427-4435
Closed Access | Times Cited: 6
Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors
Cody R. Criss, Mina S. Makary
Biology (2023) Vol. 12, Iss. 7, pp. 999-999
Open Access | Times Cited: 13
Cody R. Criss, Mina S. Makary
Biology (2023) Vol. 12, Iss. 7, pp. 999-999
Open Access | Times Cited: 13
Unveiling the prognostic role of blood inflammatory indexes in a retrospective cohort of patients undergoing liver resection for intrahepatic cholangiocarcinoma
Flavio Milana, Michela Anna Polidoro, Cristiana Soldani, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 11, pp. 7088-7096
Open Access | Times Cited: 5
Flavio Milana, Michela Anna Polidoro, Cristiana Soldani, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 11, pp. 7088-7096
Open Access | Times Cited: 5
Noninvasive diagnosis of liver cirrhosis: qualitative and quantitative imaging biomarkers
Tianying Zheng, Yali Qu, Jie Chen, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 6, pp. 2098-2115
Closed Access | Times Cited: 4
Tianying Zheng, Yali Qu, Jie Chen, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 6, pp. 2098-2115
Closed Access | Times Cited: 4
Long‐term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma
Clémentine Alitti, Agnès Rode, H. Trillaud, et al.
Liver International (2024) Vol. 44, Iss. 6, pp. 1363-1372
Closed Access | Times Cited: 4
Clémentine Alitti, Agnès Rode, H. Trillaud, et al.
Liver International (2024) Vol. 44, Iss. 6, pp. 1363-1372
Closed Access | Times Cited: 4
Biliary tract cancer
Kjetil Søreide, Cristina Dopazo, Frederik Berrevoet, et al.
European Journal of Surgical Oncology (2024), pp. 108489-108489
Open Access | Times Cited: 4
Kjetil Søreide, Cristina Dopazo, Frederik Berrevoet, et al.
European Journal of Surgical Oncology (2024), pp. 108489-108489
Open Access | Times Cited: 4
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Jasmin Elurbide, Leticia Colyn, M. Ujúe Latasa, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 116-127
Closed Access | Times Cited: 4
Jasmin Elurbide, Leticia Colyn, M. Ujúe Latasa, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 116-127
Closed Access | Times Cited: 4
Preoperative prediction of lymph node metastasis in intrahepatic cholangiocarcinoma: an integrative approach combining ultrasound-based radiomics and inflammation-related markers
Yuting Peng, Jin-shu Pang, Peng Lin, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Yuting Peng, Jin-shu Pang, Peng Lin, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment
Fuling Huang, Ye‐Ying Fang, Jiaying Wen, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Fuling Huang, Ye‐Ying Fang, Jiaying Wen, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Outcomes and Role of Lymphadenectomy in Hypervascular Intrahepatic Cholangiocarcinoma Based on CT‐Vascularity
Xuefeng Li, Tomoaki Yoh, Kotaro Shimada, et al.
World Journal of Surgery (2025)
Open Access
Xuefeng Li, Tomoaki Yoh, Kotaro Shimada, et al.
World Journal of Surgery (2025)
Open Access
Application value of 18F-FDG PET/CT in soft tissue metastasis of intrahepatic cholangiocarcinoma: a case report and literature review
Yan Liu, Xiaohui Sun, Yü Liu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Yan Liu, Xiaohui Sun, Yü Liu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Management of intrahepatic cholangiocarcinoma: a review for clinicians
Matteo Colangelo, Marcello Di Martino, Michela Anna Polidoro, et al.
Gastroenterology report (2025) Vol. 13
Open Access
Matteo Colangelo, Marcello Di Martino, Michela Anna Polidoro, et al.
Gastroenterology report (2025) Vol. 13
Open Access
Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma
C. O'Donnell, Umair Majeed, Michael Rutenberg, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 82-82
Open Access
C. O'Donnell, Umair Majeed, Michael Rutenberg, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 82-82
Open Access
